1TATEMOTO K,HOSOYA M,HABATA Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophys Res Commun,1998,251:471-476.
2HOSOYA M,KAWAMATA Y,FUKUSUMI S,et al.Molecular and functional characteristics of APJ.Tissue distribution of mRNA and interaction with the endogenous ligand apelin[J].J Biol Chem,2000,275:21061-21067.
3KAWAMATA Y,HABATA Y,FUKUSUMI S,et al.Molecular properties of apelin:tissue distribution and receptor binding[J].Biochim Biophys Acta,2001,1538:162-171.
4LEE D K,CHENG R,NGUYEN T,et al.Characterization of apelin,the ligand for the APJ receptor[J].J Neurochem,2000,74:34-41.
5O'CARROLL A M,SELLBY T L,PALKOVITS M,et al.Distribution of mRNA encoding B78/APJ,the rat homologue of the human APJ receptor,and its endogenous ligand apelin in brain and peripheral tissues[J].Biochim Biophys Acta,2000,492:72-80.
6SZOKODI I,TAVI P,FOLDS G,et al.Apelin,the novel endogenous ligand of the orphan receptor APJ,regulates cardiac contractility[J].Cire Res,2002,91:434-440.
7O'DOWD B F,HEIBER M,CHAN A,et al.A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11[J].Gene,1993,136:355-60.
8MASRI B,KNIBIEHLER B,AUDIGIER Y.Apelin signaling:a promising pathway from cloning to pharmacology[J].Cell Signal,2005,17:415-426.
9KLEINZ M J,DAVENPORT A P.Emerging roles of apelin in biology and medicine[J].Pharmacol Ther,2005,107:198-211.
10KLEINZ M J,DAVENPORT A P.Immunocytochemical localization 0f the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells[J].Regul Pept,2004,118:119-l25.
2Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophy Res Commun,1998,251(2):471-476.
4Ishida J,Hashimoto T,Hashimoto Y,et al.Regulatory roles for APJ,a seven-transmembrane receptor related to angiotensin-type1 receptor in blood pressure in vivo[J].J Biol Chem,2004,279(25):26274-26279.
5Lee DK,Saldivia VR,Nguyen T,et al.Modification of the terminal residue of apelin-13 antagonizes its hypotensive action[J].Endocrinology,2005,146(1):231-236.
3Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ reeeptor[J]. Bioehem Biophys Res Commun, 1998,251 (2) : 471- 476.
4O'Carroll AM, Sellby TL, Palkovits M, et al. Distribution of mRNA encoding B78/APJ, the rat homologue of the human APJ receptor, and its endogenous ligand Apelin in brain and peripheral tissues[J]. Bioehim Biophys Acta, 2000,492 (1) : 72-80.
5Castan-Laurell L, Vitkova M, Daviaud D, et al. Effect of hypocalorie diet-induced weight loss in obese women on plasma Apelin and adipose tissue expression of Apelin and APJ[J]. Eur J Endocrinol,2008,158(6) :905-910.
6Daviaud D, Boucher J, Gesta S, et al. TNFa up-regulates apelin expression in human and mouse adipose tissue [J]. FASEB J, 2006,20(9) : 1528-1530.
7Iwanaga Y, Kihara Y, Takenaka H, et al. Down-regulation of cardiac Apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system[J].J Mol Cell Cardiol,2006,41(5):798-806.
8Bogaert YE, Linas S. The role of obesity in the pathogenesis of hypertension[J]. Nature Clinical Practice, 2009,5 ( 2 ) :101-111.
9Reed BC, Lane MD. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipoeytes [J].Biochemistry, 1980, 77 (1) :285-289.
10Hung WW, Hsieh TJ, Lin T, et al. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes[J].Cardiovasc Drugs Ther (online), 2010, doi: 10. 1007/s10557- 010-6274-4.
